Europe Companion Animal Diagnostics Market Analysis and Forecast by Size, Share, Growth, Trends 2031

Coverage: Product (Consumables and Instruments), Companion Animal (Dogs, Cats, Horses, and Others), Technology (Immunodiagnostics, Molecular Diagnostics, Clinical Biochemistry, Hematology, Urinalysis, and Others), Application (Clinical Pathology, Bacteriology, Parasitology, Virology, and Others), and End Users (Diagnostic and Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others)

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031
  • Status : Published
  • Report Code : TIPRE00013013
  • Category : Life Sciences
  • No. of Pages : 162
  • Available Report Formats : pdf-format excel-format
  • Last update date : March 19, 2026
Europe Companion Animal Diagnostics Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: March 19, 2026   |   Report Code: TIPRE00013013 Email: sales@theinsightpartners.com

2024 Market Size

US$ 1,207.4 Mn

Base year value

2031 Forecast

US$ 2,267.4 Mn

Projected by 2031

CAGR 2025-2031

9.5 %

Growth rate

Addressable Market

US$ 12,351.94 Mn

(2025-2031)

The Europe Companion Animal Diagnostics Market size is expected to reach US$ 2,267.4 Million by 2031 from US$ 1,207.4 Million in 2024. The market is estimated to record a CAGR of 9.5% from 2025 to 2031.

Executive Summary and Europe Companion Animal Diagnostics Market Analysis:

Europe's companion animal diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Countries like Germany and the UK are expected to be the most significant companion animal diagnostics markets. The European market is growing significantly due to the presence of prominent players, technological advancements, and the awareness among pet owners about the importance of preventive healthcare.

Europe has stringent animal health regulations, and it emphasizes animal welfare, which encourages using accurate diagnostic tools to ensure proper disease management and control. Countries like Germany, France, and the UK have well-established veterinary infrastructures and government initiatives supporting animal health, stimulating market expansion.

The demand for advanced diagnostic services drives veterinary clinics and hospitals to adopt advanced testing technologies, contributing to the market's growth. Furthermore, the need for pet insurance is emphasized by the ongoing increase in veterinary costs, linked to treatment improvements and rising veterinary service costs, including diagnostics. Increasing awareness about pet healthcare, including pet health insurance, drives market expansion.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Europe Companion Animal Diagnostics Market: Strategic Insights

europe-companion-animal-diagnostics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Companion Animal Diagnostics Market Segmentation Analysis:

  • By Product, the Europe Companion Animal Diagnostics Market is segmented into Consumables and Instruments. Consumables held the largest share of the market in 2024.
  • By Companion Animal, the Europe Companion Animal Diagnostics Market is segmented into Dogs, Cats, Horses, and Others. Dogs held the largest share of the market in 2024.
  • By Technology, the Europe Companion Animal Diagnostics Market is segmented into Immunodiagnostics, Molecular Diagnostics, Clinical Biochemistry, Hematology, Urinalysis, and Others. Immunodiagnostics held the largest share of the market in 2024.
  • By Application, the Europe Companion Animal Diagnostics Market is segmented into Clinical Pathology, Bacteriology, Parasitology, Virology, and Others. Clinical Pathology held the largest share of the market in 2024.
  • By End Users, the Europe Companion Animal Diagnostics Market is segmented into Diagnostic and Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others. Veterinary Hospitals and Clinics held the largest share of the market in 2024.

Europe Companion Animal Diagnostics Market Report Scope

Report Attribute Details
Market size in 2024 US$ 1,207.4 Million
Market Size by 2031 US$ 2,267.4 Million
CAGR (2025 - 2031) 9.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Consumables
  • Instruments
By Companion Animal
  • Dogs
  • Cats
  • Horses
  • Others
By Technology
  • Immunodiagnostics
  • Molecular Diagnostics
  • Clinical Biochemistry
  • Hematology
  • Urinalysis
  • Others
By Application
  • Clinical Pathology
  • Bacteriology
  • Parasitology
  • Virology
  • Others
Regions and Countries Covered Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe
Market leaders and key company profiles
  • Zoetis Inc
  • Idexx Laboratories Inc
  • Innovative Diagnostics SAS
  • Tianjin LOCMEDT Technologies Co Ltd
  • ARI Medical Technology Co Ltd
  • Demeditec Diagnostics GmbH

Europe Companion Animal Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Companion Animal Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

europe-companion-animal-diagnostics-market-cagr

Europe Companion Animal Diagnostics Market Outlook

Small and big companies operating in the companion animal diagnostics market are increasingly adopting strategies such as geographic expansion, product development, and technological advancements to boost their revenues. A few recent developments in the companion animal diagnostics market are mentioned below:

  • In July 2024, EKF Diagnostics launched the Biosen C-Line, the latest glucose and lactate analyzer invented for improved usability. It features a touch screen and enhanced connectivity choices to incorporate seamlessly with hospital and lab IT systems via EKF Link. This benchtop analyzer provides exact glucose and lactate measurements, used in clinical settings for diabetes management and by elite sports teams for tracking lactate production in training.
  • In Europe, Zoetis has added AI Urine Sediment Analysis to its Vetscan Imagyst platform. This new tool was introduced in September 2025. It allows veterinary clinics to perform sediment analysis on fresh urine samples right in the clinic, giving results within minutes. The system uses deep learning AI to identify important components such as red and white blood cells, epithelial cells, crystals, casts, and bacteria. This helps veterinarians make timely and informed treatment choices for dogs and cats. The AI Urine Sediment Analysis application is now available in several European countries. These include France, Belgium, the Netherlands, Luxembourg, Germany, Switzerland, Austria, Italy, and Spain. There are also plans for wider availability in Central and Eastern Europe in the coming years.

Therefore, the active participation of market players in product launches, expansions, partnerships, and mergers & acquisitions is expected to create lucrative growth opportunities in the companion animal diagnostics market in the coming years.

Europe Companion Animal Diagnostics Market Country Insights

By country, the Europe Companion Animal Diagnostics Market is segmented into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2024.

Germany has a well-developed animal diagnostics sector, with private and public laboratories providing various services. The market is experiencing growth, focusing on rapid on-site diagnostics and advanced technologies such as molecular biology and genomics. For instance, the Institute for Animal Health of LUFA Nord-West, situated in Oldenburg (Germany), has a wide variety of services on offer covering animal health to farmers, vets, breeding associations, and trade firms. It's an accredited diagnostic laboratory that warrants consistently reliable results through its quality assurance system.

The presence of prominent market players favors the progress of the companion animal diagnostics market in Germany. In April 2024, Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, launched the advanced in-hospital Nu. Q Canine Cancer Test in Germany. Moreover, in November 2022, INDICAL launched an updated and even more efficient range of Virotype 2.0 PCR kits. The latest Virotype 2.0 family cycling protocol and reaction setup kits from INDICAL are validated, updated, and streamlined for optimal performance. They feature new product designs and, most significantly, share one family cycling protocol across all assays.

Europe Companion Animal Diagnostics Market Company Profiles

Some of the key players operating in the market include Zoetis Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Tianjin LOCMEDT Technologies Co Ltd, ARI Medical Technology Co Ltd, and Demeditec Diagnostics GmbH.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Europe Companion Animal Diagnostics Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations
  • Industry trade journals and other relevant publications
  • Government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research
  • Enhance the expertise and market understanding of the analysis team
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA